Trial Results: ECOG-ACRIN research round-up – Summer 2025 - ECOG-ACRIN Advocacy Blog
Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting| ECOG-ACRIN Advocacy Blog
In this interview, a champion for this rare cancer shares her journey and offers tips for seeking support The post From caregiver to catalyst: Annie Achee is on a mission to raise awareness about sarcoma and advance research appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
This clinical trial aims to improve treatment for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy The post Now Enrolling: The CLEAR research study is testing a new treatment combination for patients with operable non-small cell lung cancer appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
For Sarcoma Awareness Month, we highlight two actively recruiting clinical trials for patients with this rare cancer, which has had few treatment advances The post Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with sarcoma appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting| ECOG-ACRIN Advocacy Blog
Four tips for creating and maintaining a strong patient-oncologist relationship The post Building a lasting bond: Your oncologist as partner through good and bad times appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
This study is for patients who are in remission after their initial treatment for peripheral T-cell lymphoma The post Now Enrolling: The PTCL-STAT research study is testing the use of stem cell transplants for patients with an aggressive type of lymphoma appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
These four actively recruiting clinical trials are exploring possible new treatment approaches The post Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG| ECOG-ACRIN Advocacy Blog
Real-world data and real-world evidence are important when it comes to cancer research because they can complement and expand findings from randomized clinical trials The post Real-world data 101: an overview appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
This registry study is collecting real-world data on patients with advanced, EGFR-positive non-small cell lung cancer who may not have had the opportunity, wanted to, or been eligible to enroll in a trial The post Now Enrolling: This lung cancer patient registry study by PrECOG aims to better understand an FDA-approved treatment appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting| ECOG-ACRIN Advocacy Blog
